HK Stock MarketDetailed Quotes

01858 CHUNLI MEDICAL

Watchlist

8.670
-0.040-0.46%

Market Closed Mar 4 16:08 CST

3.33BMarket Cap24.63P/E (TTM)

CHUNLI MEDICAL Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

Turnover

----

-35.84%508.28M

-29.70%380.13M

-9.95%221.85M

----

4.24%792.16M

-5.37%540.71M

-4.18%246.36M

8.43%1.2B

5.79%759.96M

Operating income

-33.32%805.86M

-35.84%508.28M

-29.70%380.13M

-9.95%221.85M

0.58%1.21B

4.24%792.16M

-5.37%540.71M

-4.18%246.36M

8.43%1.2B

5.79%759.96M

Operating expenses

32.85%-156.04M

27.50%-108.25M

25.51%-58.04M

-17.08%-232.37M

-2.55%-149.3M

-55.17%-77.92M

-13.60%-288.08M

-18.58%-198.48M

Gross profit

-37.08%352.24M

-30.54%271.88M

-2.75%163.81M

-0.30%559.78M

-8.08%391.41M

-18.59%168.44M

6.90%913.53M

1.90%561.49M

Selling expenses

----

30.07%-163.46M

33.20%-111.48M

2.80%-63.15M

----

-1.56%-233.75M

-7.66%-166.89M

18.69%-64.97M

-14.45%-391.47M

1.55%-230.17M

Administrative expenses

----

-8.46%-31.36M

-12.41%-21.31M

-6.69%-7.52M

----

-17.15%-28.91M

-22.59%-18.96M

-17.28%-7.05M

-26.63%-38.84M

-15.36%-24.68M

Research and development expenses

----

13.13%-99.68M

9.27%-67.66M

-5.17%-34.99M

----

-9.26%-114.74M

-3.16%-74.57M

-0.47%-33.27M

-54.84%-162.34M

-61.11%-105.01M

Profit from asset sales

----

7,237.14%39.21K

--39.21K

----

-102.17%-549.43

----

70.33%25.31K

Revaluation surplus

----

-14.03%6.08M

6.57%4.67M

-31.73%1.38M

----

8.14%7.07M

10.60%4.38M

19.29%2.02M

--9.49M

--6.54M

-Changes in the fair value of other assets

----

-14.03%6.08M

6.57%4.67M

-31.73%1.38M

----

8.14%7.07M

10.60%4.38M

19.29%2.02M

--9.49M

--6.54M

Impairment and provision

----

-43.49%-16.47M

7.86%-11.02M

31.10%-5.48M

----

14.50%-11.48M

28.70%-11.96M

-58.09%-7.95M

-10.91%-30.27M

-4.13%-13.43M

-Other impairment is provision

----

-43.49%-16.47M

7.86%-11.02M

31.10%-5.48M

----

14.50%-11.48M

28.70%-11.96M

-58.09%-7.95M

-10.91%-30.27M

-4.13%-13.43M

Special items of operating profit

----

11.86%16.99M

-11.25%12.5M

10.49%6.02M

----

-47.15%15.19M

128.98%14.08M

567.34%5.45M

25.68%21.94M

85.95%28.73M

Operating profit

-57.28%130.71M

-68.86%58.37M

-45.10%73.27M

-4.75%58.24M

-0.89%305.98M

-12.73%187.42M

-20.96%133.47M

-26.22%61.14M

-13.75%308.73M

-5.28%214.75M

Financing cost

----

-16.81%7.09M

80.47%9.01M

-9.55%1.08M

----

-48.62%8.52M

-13.57%4.99M

-14.82%1.2M

109.24%20.17M

94.68%16.58M

Special items of earning before tax

----

1,530.27%713.98K

909.91%783.77K

819.68%839.1K

----

97.78%-49.92K

103.46%77.61K

91.23%-116.59K

3,843.45%7.97M

-1,295.24%-2.25M

Earning before tax

-56.98%131.6M

-66.22%66.16M

-40.04%83.07M

-3.31%60.16M

-9.19%305.91M

-14.49%195.88M

-19.64%138.54M

-24.99%62.23M

-8.30%336.88M

-2.55%229.07M

Tax

----

66.53%-5.16M

67.26%-4.11M

20.53%-5.06M

----

20.47%-15.4M

18.57%-12.55M

28.73%-6.36M

35.22%-29.16M

37.32%-19.37M

After-tax profit from continuing operations

-66.20%61.01M

-37.33%78.96M

-1.35%55.11M

-13.94%180.48M

-19.75%125.99M

-24.53%55.86M

-4.54%307.72M

2.71%209.71M

Earning after tax

-66.20%61.01M

-37.33%78.96M

-1.35%55.11M

-13.94%180.48M

-19.75%125.99M

-24.53%55.86M

-4.54%307.72M

2.71%209.71M

Minority profit

----

-0.29%-142.8K

29.05%-65.18K

---92.55K

----

---142.39K

---91.88K

----

Profit attributable to shareholders

-55.01%124.98M

-66.14%61.15M

-37.32%79.03M

-1.18%55.2M

-9.72%277.82M

-13.87%180.62M

-19.69%126.08M

-24.53%55.86M

-4.54%307.72M

2.71%209.71M

Basic earnings per share

-54.17%0.33

-65.96%0.16

-36.36%0.21

-6.67%0.14

-10.00%0.72

-14.55%0.47

-19.51%0.33

-21.05%0.15

-13.98%0.8

-6.78%0.55

Diluted earnings per share

-65.96%0.16

-36.36%0.21

-6.67%0.14

-14.55%0.47

-19.51%0.33

-21.05%0.15

-13.98%0.8

-6.78%0.55

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified Opinion

Auditor

Daxin Certified Public Accountants (Special General Partnership)

	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022
Turnover	----	-35.84%508.28M	-29.70%380.13M	-9.95%221.85M	----	4.24%792.16M	-5.37%540.71M	-4.18%246.36M	8.43%1.2B	5.79%759.96M
Operating income	-33.32%805.86M	-35.84%508.28M	-29.70%380.13M	-9.95%221.85M	0.58%1.21B	4.24%792.16M	-5.37%540.71M	-4.18%246.36M	8.43%1.2B	5.79%759.96M
Operating expenses		32.85%-156.04M	27.50%-108.25M	25.51%-58.04M		-17.08%-232.37M	-2.55%-149.3M	-55.17%-77.92M	-13.60%-288.08M	-18.58%-198.48M
Gross profit		-37.08%352.24M	-30.54%271.88M	-2.75%163.81M		-0.30%559.78M	-8.08%391.41M	-18.59%168.44M	6.90%913.53M	1.90%561.49M
Selling expenses	----	30.07%-163.46M	33.20%-111.48M	2.80%-63.15M	----	-1.56%-233.75M	-7.66%-166.89M	18.69%-64.97M	-14.45%-391.47M	1.55%-230.17M
Administrative expenses	----	-8.46%-31.36M	-12.41%-21.31M	-6.69%-7.52M	----	-17.15%-28.91M	-22.59%-18.96M	-17.28%-7.05M	-26.63%-38.84M	-15.36%-24.68M
Research and development expenses	----	13.13%-99.68M	9.27%-67.66M	-5.17%-34.99M	----	-9.26%-114.74M	-3.16%-74.57M	-0.47%-33.27M	-54.84%-162.34M	-61.11%-105.01M
Profit from asset sales	----	7,237.14%39.21K	--39.21K	----	----	-102.17%-549.43	----	----	70.33%25.31K	70.33%25.31K
Revaluation surplus	----	-14.03%6.08M	6.57%4.67M	-31.73%1.38M	----	8.14%7.07M	10.60%4.38M	19.29%2.02M	--9.49M	--6.54M
-Changes in the fair value of other assets	----	-14.03%6.08M	6.57%4.67M	-31.73%1.38M	----	8.14%7.07M	10.60%4.38M	19.29%2.02M	--9.49M	--6.54M
Impairment and provision	----	-43.49%-16.47M	7.86%-11.02M	31.10%-5.48M	----	14.50%-11.48M	28.70%-11.96M	-58.09%-7.95M	-10.91%-30.27M	-4.13%-13.43M
-Other impairment is provision	----	-43.49%-16.47M	7.86%-11.02M	31.10%-5.48M	----	14.50%-11.48M	28.70%-11.96M	-58.09%-7.95M	-10.91%-30.27M	-4.13%-13.43M
Special items of operating profit	----	11.86%16.99M	-11.25%12.5M	10.49%6.02M	----	-47.15%15.19M	128.98%14.08M	567.34%5.45M	25.68%21.94M	85.95%28.73M
Operating profit	-57.28%130.71M	-68.86%58.37M	-45.10%73.27M	-4.75%58.24M	-0.89%305.98M	-12.73%187.42M	-20.96%133.47M	-26.22%61.14M	-13.75%308.73M	-5.28%214.75M
Financing cost	----	-16.81%7.09M	80.47%9.01M	-9.55%1.08M	----	-48.62%8.52M	-13.57%4.99M	-14.82%1.2M	109.24%20.17M	94.68%16.58M
Special items of earning before tax	----	1,530.27%713.98K	909.91%783.77K	819.68%839.1K	----	97.78%-49.92K	103.46%77.61K	91.23%-116.59K	3,843.45%7.97M	-1,295.24%-2.25M
Earning before tax	-56.98%131.6M	-66.22%66.16M	-40.04%83.07M	-3.31%60.16M	-9.19%305.91M	-14.49%195.88M	-19.64%138.54M	-24.99%62.23M	-8.30%336.88M	-2.55%229.07M
Tax	----	66.53%-5.16M	67.26%-4.11M	20.53%-5.06M	----	20.47%-15.4M	18.57%-12.55M	28.73%-6.36M	35.22%-29.16M	37.32%-19.37M
After-tax profit from continuing operations		-66.20%61.01M	-37.33%78.96M	-1.35%55.11M		-13.94%180.48M	-19.75%125.99M	-24.53%55.86M	-4.54%307.72M	2.71%209.71M
Earning after tax		-66.20%61.01M	-37.33%78.96M	-1.35%55.11M		-13.94%180.48M	-19.75%125.99M	-24.53%55.86M	-4.54%307.72M	2.71%209.71M
Minority profit	----	-0.29%-142.8K	29.05%-65.18K	---92.55K	----	---142.39K	---91.88K	----	----	----
Profit attributable to shareholders	-55.01%124.98M	-66.14%61.15M	-37.32%79.03M	-1.18%55.2M	-9.72%277.82M	-13.87%180.62M	-19.69%126.08M	-24.53%55.86M	-4.54%307.72M	2.71%209.71M
Basic earnings per share	-54.17%0.33	-65.96%0.16	-36.36%0.21	-6.67%0.14	-10.00%0.72	-14.55%0.47	-19.51%0.33	-21.05%0.15	-13.98%0.8	-6.78%0.55
Diluted earnings per share		-65.96%0.16	-36.36%0.21	-6.67%0.14		-14.55%0.47	-19.51%0.33	-21.05%0.15	-13.98%0.8	-6.78%0.55
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--
Auditor	--	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks